Market Access & Pricing Strategy Focus Groups

Build data-driven pricing strategies and market access plans with stakeholder insights through structured engagements

ExtendMed's Health Expert Connect™ platform enables pharmaceutical teams to conduct sophisticated market access research and pricing strategy focus groups—convening payers, insurers, hospital administrators and other decision-makers to inform market positioning and coverage approaches.

Get a demo How it works

Pricing and reimbursement decisions demand real stakeholder input

Commercial teams often approach market access without adequate input from the stakeholders who determine formulary inclusion and coverage decisions. We see this lead to pricing missteps, reimbursement barriers and slower market adoption when evidence-based positioning is essential.

ExtendMed transforms market access research from fragmented stakeholder outreach into comprehensive insight-gathering programs that synthesize diverse perspectives across payers, insurers and administrators through systematic engagement and analysis.

 

See Health Expert ConnectTM in action

Click any tile to explore our market access capabilities.

stakeholder survey

Conduct blinded stakeholder surveys

Launch anonymized surveys to collect unbiased feedback from payers and administrators about current treatment landscapes, unmet needs and coverage priorities. Gather baseline insights that identify gaps your product addresses before deeper engagement begins.

multi stakeholder focus group

Host multi-stakeholder focus groups

Facilitate structured discussions with representatives from diverse organizations— entities across different states, hospital systems, pharmacy benefit managers and other decision-makers. Draw out perspectives that reveal priorities, concerns and common themes across stakeholder types.

evidence based value prop

Build evidence-based value propositions

Use stakeholder feedback to craft compelling cases for formulary inclusion grounded in real decision-maker perspectives. Demonstrate how your product fills treatment gaps while delivering improved outcomes at competitive costs compared to existing alternatives.

 

sythesized research

Synthesize year-long research programs

Leverage platform analysis and AI tools to compile insights from multiple engagements over extended research periods. Turn months of focus groups, surveys and discussions into cohesive strategic recommendations that guide pricing and access decisions.

Everything you need for strategic market access research

Validate

  • Pricing approaches with actual payer and administrator input
  • Value propositions against stakeholder priorities and concerns
  • Formulary inclusion strategies based on decision-maker feedback
  • Coverage barriers and reimbursement positioning early in development

Collect

  • Anonymized, blinded feedback to reduce bias in initial research
  • Diverse perspectives from payers, insurers and health system leaders
  • Both quantitative survey data and qualitative discussion insights
  • Comprehensive stakeholder intelligence across multiple sessions

Refine

  • Market access strategy informed by real decision-maker input
  • Pricing positioning supported by stakeholder research findings
  • Value messaging refined to address specific payer concerns
  • Launch readiness with validated coverage and reimbursement approach

See how we help teams like yours

Mediar Therapeutics needed rapid, cross-functional insights in fibrosis. We convened a virtual advisory board of top experts, facilitated real-time collaboration and fast-tracked the feedback loop.

extendmed and mediar logos

Read the full case study

A global oncology biopharma used Health Expert Connect™ to orchestrate 1:1s, a dinner forum and follow-ups across ASCO and EHA—centralizing schedules, compliance tracking and KOL analytics to deepen relationships at scale.

Read the full case study

An inflammatory-disease company expanding into nephrology ran asynchronous boards, surveys and chart audits to learn the market fast, refine messaging and engage specialists every six weeks—accelerating entry with lower spend.

Read the full case study

A small pharma prepping first launch scaled stakeholder engagement with a lean team, mixing virtual meetings and ongoing discussion to surface payer hurdles and patient insights early, de-risk and beat rivals to key KOLs.

Read the full case study
jamie arviso ultragenyx profile
Jaime Arvizo Vice President, Head of Medical Affairs

In 25 years of working with vendors, ExtendMed stands at the top of the list. They’re strategic partners, arming my staff with vital statistics and sharing their experience and ideas for the future. They’re nimble and they understand our business. They’ve anticipated issues, recommended new directions and implemented our decisions efficiently.”

ultragenyx-white

Vice President, Group Account DirectorGlobal Medical Comms Firm

We feel your team does the best job out of any vendor we have used for virtual advisory boards.”

Dr. Michael Chang Vice President, Medical Affairs

The virtual format enables more frequent touchpoints while reducing time commitments for busy specialists. We can build relationships and confidence across multiple specialty areas in ways that traditional in-person meetings never could. The platform makes it possible to engage specialists who would never attend a weekend conference but will participate in targeted discussions relevant to their practice."

Compare market access research with vs. without ExtendMed

Click through each category to see how Health Expert Connect™ compares to traditional approaches—and what teams gain when they partner with us.

Stakeholder diversity and reach with ExtendMed

Engage diverse stakeholder groups including payers from different organizations, hospital administrators and pharmacy decision-makers without geographic constraints. Access perspectives across different health systems, insurance entities and regional markets that strengthen your understanding of access barriers.

Stakeholder diversity and reach without ExtendMed

Limited stakeholder diversity due to logistical challenges of coordinating multiple organizations. Risk missing critical insights from different payer types, regional variations and diverse decision-maker perspectives that could inform strategy.

Research depth and continuity with ExtendMed

Conduct systematic multi-month research programs with consistent stakeholder engagement over time. Build longitudinal understanding of priorities and concerns through repeated touch points that develop deeper relationships and more nuanced insights.

Research depth and continuity without ExtendMed

One-off stakeholder interactions that lack continuity and depth. Difficulty maintaining research momentum across multiple sessions or synthesizing insights from isolated engagements into a coherent strategy.

Anonymized feedback collection with ExtendMed

Gather blinded, anonymized survey responses that reduce stakeholder bias and encourage candid feedback about current treatments, gaps and priorities. Create safe environments for honest assessment of competitive products and unmet needs.

Anonymized feedback collection without ExtendMed

Stakeholder reluctance to provide candid feedback in identified settings. Biased responses that don't reveal true concerns. Competitive positioning challenges or barriers to formulary inclusion.

Data synthesis capabilities without ExtendMed

Centralized platform analysis and AI tools compile insights from surveys, focus groups and discussions into comprehensive strategic recommendations. Identify patterns across multiple engagements and stakeholder types that inform evidence-based pricing decisions.

Data synthesis capabilities with ExtendMed

Manual synthesis of disconnected research activities across different tools and platforms. Difficulty identifying themes across stakeholder groups or compiling year-long research into an actionable pricing and access strategy.

Partnership with market access specialists
with ExtendMed

Technology platform that integrates seamlessly with market access consultants and specialists. Enable your strategic partners to leverage sophisticated engagement tools while maintaining their expert guidance and methodological expertise.

Partnership with market access specialists without ExtendMed

Market access specialists are limited by inadequate technology infrastructure. Strategic expertise is hampered by platform limitations that reduce research efficiency and insight quality.

Investment efficiency with ExtendMed

Cost-effective virtual engagement eliminates travel, venue and coordination expenses while enabling broader stakeholder reach. Conduct comprehensive multi-month research programs within reasonable budgets that support thorough market access validation.

Investment efficiency without ExtendMed

High costs for in-person stakeholder meetings limit research frequency and breadth. Budget constraints force compromises in stakeholder diversity, research depth or program duration that weaken strategic foundation.

Better market access research in just three steps

Nobody wants to complicate launch preparation. That's why we've made implementing comprehensive stakeholder research straightforward and strategic—from initial planning to actionable pricing insights.

Express your interest

Share your market access objectives, target stakeholder groups and current research challenges using the form below. We'll learn about your therapeutic area, competitive landscape and launch timeline.

Get a tailored demo

We'll demonstrate how our platform transforms stakeholder engagement for market access and pricing strategy development. You'll see exactly how it supports blinded surveys, multi-stakeholder focus groups and comprehensive insight synthesis.

Launch your research program

We'll guide you through research design, stakeholder recruitment and analysis methodology. Your market access program will have dedicated platform support and strategic guidance throughout the engagement cycle.

A few FAQs

Still have questions? Here are answers to the most common ones we hear from organizations exploring Health Expert Connect™ for market access and pricing strategy.

How quickly can we start gathering stakeholder feedback for our launch preparations?

We recommend beginning market access research about a year out from FDA approval. This timeline allows you to systematically engage stakeholders, gather comprehensive insights and refine your strategy while companies are building their sales teams and MSL presence.

Can we conduct blinded research to get unbiased stakeholder feedback?

Yes. Our platform supports anonymized survey collection that enables blinded focus group approaches. This helps you understand current treatment options, identify gaps, and gather candid stakeholder input without bias.

How do you help us synthesize insights from multiple stakeholder engagements?

Our platform's analysis and AI tools compile research findings from surveys, focus groups and discussions conducted over extended periods. We transform months of stakeholder engagements into comprehensive reports with actionable strategic recommendations.

What types of stakeholders should we engage for market access research?

Typical stakeholder groups include payer representatives, entities across different states, hospital administrators, pharmacy benefit managers and other healthcare decision-makers who influence formulary inclusion and coverage decisions.

Do you provide the market access expertise or just the technology platform?

We're typically brought in by companies that offer market access expertise who need our technology infrastructure to engage stakeholders effectively. Our platform enables market access specialists to execute their strategic research programs efficiently while we provide the engagement tools.

How does this help us build the case for formulary inclusion?

You'll use stakeholder feedback to demonstrate how your product fills treatment gaps identified by payers themselves. The research helps you articulate value propositions focused on better outcomes at competitive costs compared to existing alternatives.

What's the typical duration for a comprehensive market access research program?

Many programs run for about a year, with multiple stakeholder engagements including surveys, focus groups and follow-up discussions. This extended timeline allows you to gather diverse perspectives and refine your approach based on ongoing feedback.

I have another question.

We’re happy to answer it. Contact us directly or use the form above to request a demo and start the conversation.

How long are you going to wait to develop data-driven market access strategies?

Request a demo today.

No pressure. No spam. Just a quick conversation with our experts. Submit the form below to express your interest in a demo. We'll be in touch within one business day. And don't worry—we value your privacy as much as you do.